Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2.
Ross KA, Kelly S, Phadke KS, Peroutka-Bigus N, Fasina O, Siddoway A, Mallapragada SK, Wannemuehler MJ, Bellaire BH, Narasimhan B.
Ross KA, et al. Among authors: kelly s.
Acta Biomater. 2024 Jun 4:S1742-7061(24)00300-3. doi: 10.1016/j.actbio.2024.05.048. Online ahead of print.
Acta Biomater. 2024.
PMID: 38844193